Continuous subcutaneous neostigmine in the management of severe myasthenia gravis.
D000328:Adult; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000008:administration & dosage* / Q000627:therapeutic use
D009388:Neostigmine